PROQR THRAPEUTICS N V shareholders Q2 2023

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

PROQR THRAPEUTICS N V shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$3,095,1724.09%
Privium Fund Management B.V. 5,344,446$8,658,0031.82%
DAFNA Capital Management LLC 940,582$1,523,7430.42%
Opaleye Management Inc. 653,000$1,057,8600.25%
Ikarian Capital, LLC 472,625$765,6530.12%
EcoR1 Capital, LLC 2,980,016$4,827,6260.12%
Monaco Asset Management SAM 237,517$384,7780.11%
FRANKLIN STREET ADVISORS INC /NC 150,000$2430.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$5,873,2570.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 189,328$306,7110.01%
Atom Investors LP 13,107$21,2330.01%
GSA CAPITAL PARTNERS LLP 43,836$710.01%
XTX Topco Ltd 16,405$26,5760.01%
BOOTHBAY FUND MANAGEMENT, LLC 95,745$155,1070.00%
TWO SIGMA ADVISERS, LP 461,200$747,1440.00%
TWO SIGMA INVESTMENTS, LP 487,844$790,3070.00%
Squarepoint Ops LLC 134,142$217,3100.00%
PFS Partners, LLC 1,000$1,6200.00%
OneDigital Investment Advisors LLC 15,300$24,7860.00%
Centiva Capital, LP 23,160$37,5190.00%
External links

This page lists PROQR THRAPEUTICS N V's shareholders in Q2 2023. To view PROQR THRAPEUTICS N V's shareholder history, click here.